Onderneming Cempra Inc Nasdaq
Aandelen
US15130J1097
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 48 | 03-08-20 | |
Susan Blum
DFI | Director of Finance/CFO | 52 | 01-01-16 |
Compliance Officer | 45 | - | |
Jisoo Park
PRN | Corporate Officer/Principal | - | 06-07-21 |
Kristen Allgor
HRO | Human Resources Officer | - | 16-11-20 |
John Harlow
PRN | Corporate Officer/Principal | - | 30-03-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20-04-20 |
Director/Board Member | - | 20-04-20 | |
Director/Board Member | - | 20-04-20 | |
Compliance Officer | 45 | - | |
Chief Executive Officer | 48 | 03-08-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 13 750 691 | 13 578 334 ( 98,75 %) | 0 | 98,75 % |
Bedrijfsgegevens
Melinta Therapeutics, Inc.
389 Interpace Parkway Suite 450
07054, Parsippany
+908-617-1300
http://melinta.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |